PNC Financial Services Group’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.04K Sell
88
-3,845
-98% -$219K ﹤0.01% 4323
2026
Q1
$253K Sell
3,933
-159
-4% -$14.5K ﹤0.01% 2173
2025
Q4
$532K Buy
4,092
+1,025
+33% +$141K ﹤0.01% 1615
2025
Q3
$330K Sell
3,067
-545
-15% -$59.4K ﹤0.01% 1936
2025
Q2
$333K Buy
3,612
+2,127
+143% +$167K ﹤0.01% 1847
2025
Q1
$132K Buy
+1,485
New +$129K ﹤0.01% 2477
2021
Q4
Sell
-9
Closed -$2K 4632
2021
Q3
$2K Buy
+9
New +$3.09K ﹤0.01% 4142

Other funds holding WGS

PNC Financial Services Group's WGS Position: Q2 2026 in Review

PNC Financial Services Group reduced its GeneDx Holdings (WGS) stake by 98% in Q2 2026, selling an estimated $219K and leaving 88 shares worth $6.04K. The position accounts for ﹤0.01% of the portfolio, ranked #4323.

PNC Financial Services Group first reported a position in WGS in Q3 2021 and has held it in 7 quarters since. The position peaked at $532K in Q4 2025. 86 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • PNC Financial Services Group held 88 shares of GeneDx Holdings worth $6.04K as of Q2 2026.
  • PNC Financial Services Group sold 3,845 GeneDx Holdings shares in Q2 2026, an estimated $219K.
  • GeneDx Holdings made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4323 holding.
  • PNC Financial Services Group first reported a position in GeneDx Holdings in Q3 2021 and has held it in 7 quarters since.
  • PNC Financial Services Group's GeneDx Holdings position peaked at $532K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.